{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:43:00Z","timestamp":1792651380717,"version":"4.5.0"},"reference-count":83,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T00:00:00Z","timestamp":1546214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1ZIAAI000937-14"],"award-info":[{"award-number":["1ZIAAI000937-14"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0208559","type":"journal-article","created":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T18:30:12Z","timestamp":1546281012000},"page":"e0208559","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Toll-like receptor 2 confers partial neuroprotection during prion disease"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4329-1488","authenticated-orcid":true,"given":"James A.","family":"Carroll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent","family":"Race","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Chesebro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,12,31]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"a006833","DOI":"10.1101\/cshperspect.a006833","article-title":"Prions","volume":"3","author":"DW Colby","year":"2011","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"7","key":"ref2","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/nn.3120","article-title":"Prion propagation, toxicity and degradation","volume":"15","author":"A Aguzzi","year":"2012","journal-title":"Nat Neurosci"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1146\/annurev.biochem.78.082907.145410","article-title":"Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions","volume":"78","author":"B Caughey","year":"2009","journal-title":"Annu Rev Biochem"},{"issue":"9","key":"ref4","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1172\/JCI90605","article-title":"Microglia in prion diseases","volume":"127","author":"A Aguzzi","year":"2017","journal-title":"J Clin Invest"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1099\/vir.0.80110-0","article-title":"Identification of central nervous system genes involved in the host response to the scrapie agent during preclinical and clinical infection","volume":"85","author":"S Booth","year":"2004","journal-title":"J Gen Virol"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1128\/JVI.02952-14","article-title":"Prion infection of mouse brain reveals multiple new upregulated genes involved in neuroinflammation or signal transduction","volume":"89","author":"JA Carroll","year":"2015","journal-title":"J Virol"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1006\/exnr.1997.6424","article-title":"PrP deposition, microglial activation, and neuronal apoptosis in murine scrapie","volume":"144","author":"A Williams","year":"1997","journal-title":"Exp Neurol"},{"issue":"6","key":"ref8","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1128\/JVI.02613-15","article-title":"Defining the Microglia Response during the Time Course of Chronic Neurodegeneration","volume":"90","author":"JE Vincenti","year":"2015","journal-title":"J Virol"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.devcel.2016.07.006","article-title":"Microglia: Phagocytosing to Clear, Sculpt, and Eliminate","volume":"38","author":"S Hong","year":"2016","journal-title":"Dev Cell"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.pharmthera.2013.04.013","article-title":"Microglia during development and aging","volume":"139","author":"GJ Harry","year":"2013","journal-title":"Pharmacol Ther"},{"key":"ref11","first-page":"138","article-title":"Strategies to increase the activity of microglia as efficient protectors of the brain against infections","volume":"8","author":"R Nau","year":"2014","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/0192623310387619","article-title":"Microglia: key innate immune cells of the brain","volume":"39","author":"J Kofler","year":"2011","journal-title":"Toxicol Pathol"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1017\/S1740925X12000014","article-title":"Microglia and neuronal cell death","volume":"7","author":"JL Marin-Teva","year":"2011","journal-title":"Neuron Glia Biol"},{"issue":"7","key":"ref14","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1002\/jnr.21590","article-title":"Molecular basis for detection of invading pathogens in the brain","volume":"86","author":"J Falsig","year":"2008","journal-title":"J Neurosci Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"342931","DOI":"10.1155\/2013\/342931","article-title":"Innate immunity and neuroinflammation","volume":"2013","author":"A Shastri","year":"2013","journal-title":"Mediators Inflamm"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1152\/physrev.00011.2010","article-title":"Physiology of microglia","volume":"91","author":"H Kettenmann","year":"2011","journal-title":"Physiol Rev"},{"key":"ref17","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/672395","article-title":"DAMPening inflammation by modulating TLR signalling","volume":"2010","author":"AM Piccinini","year":"2010","journal-title":"Mediators Inflamm"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1600-065X.2012.01146.x","article-title":"PAMPs and DAMPs: signal 0s that spur autophagy and immunity","volume":"249","author":"D Tang","year":"2012","journal-title":"Immunol Rev"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1385\/IR:34:2:157","article-title":"The role of complement in danger sensing and transmission","volume":"34","author":"J Kohl","year":"2006","journal-title":"Immunol Res"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1189\/jlb.0304127","article-title":"Endogenous ligands of Toll-like receptors","volume":"76","author":"MF Tsan","year":"2004","journal-title":"J Leukoc Biol"},{"key":"ref21","article-title":"Microglia Are Critical in Host Defense Against Prion Disease","author":"JA Carroll","year":"2018","journal-title":"J Virol"},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/86567","article-title":"Complement facilitates early prion pathogenesis","volume":"7","author":"MA Klein","year":"2001","journal-title":"Nat Med"},{"issue":"4","key":"ref23","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/86562","article-title":"Temporary depletion of complement component C3 or genetic deficiency of C1q significantly delays onset of scrapie","volume":"7","author":"NA Mabbott","year":"2001","journal-title":"Nat Med"},{"issue":"12","key":"ref24","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/intimm\/dxt034","article-title":"Complement protein C3 exacerbates prion disease in a mouse model of chronic wasting disease","volume":"25","author":"B Michel","year":"2013","journal-title":"Int Immunol"},{"issue":"9","key":"ref25","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.4049\/jimmunol.1201579","article-title":"Genetic depletion of complement receptors CD21\/35 prevents terminal prion disease in a mouse model of chronic wasting disease","volume":"189","author":"B Michel","year":"2012","journal-title":"J Immunol"},{"issue":"6","key":"ref26","article-title":"Relative Impact of Complement Receptors CD21\/35 (Cr2\/1) on Scrapie Pathogenesis in Mice","volume":"2","author":"SJ Kane","year":"2017","journal-title":"mSphere"},{"issue":"7","key":"ref27","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.imbio.2004.06.003","article-title":"Complement component C5 is not involved in scrapie pathogenesis","volume":"209","author":"NA Mabbott","year":"2004","journal-title":"Immunobiology"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/jnr.10474","article-title":"Complete Freund&apos;s adjuvant immunization prolongs survival in experimental prion disease in mice","volume":"71","author":"Y Tal","year":"2003","journal-title":"J Neurosci Res"},{"issue":"40","key":"ref29","doi-asserted-by":"crossref","first-page":"9275","DOI":"10.1523\/JNEUROSCI.2614-05.2005","article-title":"Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration","volume":"25","author":"C Cunningham","year":"2005","journal-title":"J Neurosci"},{"issue":"6","key":"ref30","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.bbi.2010.04.004","article-title":"Systemic challenge with the TLR3 agonist poly I:C induces amplified IFNalpha\/beta and IL-1beta responses in the diseased brain and exacerbates chronic neurodegeneration","volume":"24","author":"R Field","year":"2010","journal-title":"Brain Behav Immun"},{"issue":"9328","key":"ref31","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(02)09513-2","article-title":"Postexposure prophylaxis against prion disease with a stimulator of innate immunity","volume":"360","author":"S Sethi","year":"2002","journal-title":"Lancet"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nm987","article-title":"Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration","volume":"10","author":"M Heikenwalder","year":"2004","journal-title":"Nat Med"},{"issue":"21","key":"ref33","doi-asserted-by":"crossref","first-page":"10701","DOI":"10.1128\/JVI.00522-08","article-title":"Accelerated prion disease pathogenesis in Toll-like receptor 4 signaling-mutant mice","volume":"82","author":"DS Spinner","year":"2008","journal-title":"J Virol"},{"issue":"36","key":"ref34","doi-asserted-by":"crossref","first-page":"11929","DOI":"10.1523\/JNEUROSCI.1860-14.2014","article-title":"An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex","volume":"34","author":"Y Zhang","year":"2014","journal-title":"J Neurosci"},{"issue":"21","key":"ref35","doi-asserted-by":"crossref","first-page":"11244","DOI":"10.1128\/JVI.01413-09","article-title":"Analysis of protein levels of 24 cytokines in scrapie agent-infected brain and glial cell cultures from mice differing in prion protein expression levels","volume":"83","author":"D Tribouillard-Tanvier","year":"2009","journal-title":"J Virol"},{"issue":"19","key":"ref36","doi-asserted-by":"crossref","first-page":"10377","DOI":"10.1128\/JVI.01340-12","article-title":"Early cytokine elevation, PrPres deposition, and gliosis in mouse scrapie: no effect on disease by deletion of cytokine genes IL-12p40 and IL-12p35","volume":"86","author":"D Tribouillard-Tanvier","year":"2012","journal-title":"J Virol"},{"issue":"9","key":"ref37","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.1128\/JVI.02762-06","article-title":"Resistance to chronic wasting disease in transgenic mice expressing a naturally occurring allelic variant of deer prion protein","volume":"81","author":"K Meade-White","year":"2007","journal-title":"J Virol"},{"issue":"4","key":"ref38","doi-asserted-by":"crossref","first-page":"e1005551","DOI":"10.1371\/journal.ppat.1005551","article-title":"Prion Strain Differences in Accumulation of PrPSc on Neurons and Glia Are Associated with Similar Expression Profiles of Neuroinflammatory Genes: Comparison of Three Prion Strains","volume":"12","author":"JA Carroll","year":"2016","journal-title":"PLoS Pathog"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/msb.2009.10","article-title":"A systems approach to prion disease","volume":"5","author":"D Hwang","year":"2009","journal-title":"Mol Syst Biol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/1471-2164-7-114","article-title":"Gene expression alterations in brains of mice infected with three strains of scrapie","volume":"7","author":"PJ Skinner","year":"2006","journal-title":"BMC Genomics"},{"issue":"2","key":"ref41","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.bbrc.2004.08.124","article-title":"Gene expression profiling of scrapie-infected brain tissue","volume":"323","author":"C Riemer","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"issue":"20","key":"ref42","doi-asserted-by":"crossref","first-page":"11051","DOI":"10.1128\/JVI.78.20.11051-11060.2004","article-title":"Identification of differentially expressed genes in scrapie-infected mouse brains by using global gene expression technology","volume":"78","author":"W Xiang","year":"2004","journal-title":"J Virol"},{"issue":"9","key":"ref43","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.1923","article-title":"Complement: a key system for immune surveillance and homeostasis","volume":"11","author":"D Ricklin","year":"2010","journal-title":"Nat Immunol"},{"issue":"2","key":"ref44","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4161\/pri.3.2.9059","article-title":"Comparative prion disease gene expression profiling using the prion disease mimetic, cuprizone","volume":"3","author":"LR Moody","year":"2009","journal-title":"Prion"},{"issue":"2","key":"ref45","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/sj.icb.7100166","article-title":"Receptors for complement C5a. The importance of C5aR and the enigmatic role of C5L2","volume":"86","author":"H Lee","year":"2008","journal-title":"Immunol Cell Biol"},{"issue":"14","key":"ref46","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1016\/j.molimm.2009.04.027","article-title":"The role of the anaphylatoxins in health and disease","volume":"46","author":"A Klos","year":"2009","journal-title":"Mol Immunol"},{"issue":"1","key":"ref47","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/imr.12467","article-title":"More than complementing Tolls: complement-Toll-like receptor synergy and crosstalk in innate immunity and inflammation","volume":"274","author":"G Hajishengallis","year":"2016","journal-title":"Immunol Rev"},{"issue":"4","key":"ref48","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.it.2010.01.002","article-title":"Crosstalk pathways between Toll-like receptors and the complement system","volume":"31","author":"G Hajishengallis","year":"2010","journal-title":"Trends Immunol"},{"issue":"2","key":"ref49","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.atherosclerosis.2015.05.038","article-title":"The complement system and toll-like receptors as integrated players in the pathophysiology of atherosclerosis","volume":"241","author":"A Hovland","year":"2015","journal-title":"Atherosclerosis"},{"issue":"8","key":"ref50","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1099\/jgv.0.000876","article-title":"Statins are ineffective at reducing neuroinflammation or prolonging survival in scrapie-infected mice","volume":"98","author":"JA Carroll","year":"2017","journal-title":"J Gen Virol"},{"issue":"2","key":"ref51","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/sj.embor.embor731","article-title":"Prion pathogenesis in the absence of Toll-like receptor signalling","volume":"4","author":"M Prinz","year":"2003","journal-title":"EMBO Rep"},{"issue":"9","key":"ref52","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1128\/JVI.06326-11","article-title":"Protective role of interferon regulatory factor 3-mediated signaling against prion infection","volume":"86","author":"D Ishibashi","year":"2012","journal-title":"J Virol"},{"issue":"25","key":"ref53","doi-asserted-by":"crossref","first-page":"13766","DOI":"10.1073\/pnas.250476497","article-title":"The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors","volume":"97","author":"A Ozinsky","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"ref54","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/intimm\/13.7.933","article-title":"Discrimination of bacterial lipoproteins by Toll-like receptor 6","volume":"13","author":"O Takeuchi","year":"2001","journal-title":"Int Immunol"},{"issue":"1","key":"ref55","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4049\/jimmunol.169.1.10","article-title":"Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins","volume":"169","author":"O Takeuchi","year":"2002","journal-title":"J Immunol"},{"issue":"12","key":"ref56","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1002\/1521-4141(2002012)32:12<3337::AID-IMMU3337>3.0.CO;2-I","article-title":"Differential recognition of structural details of bacterial lipopeptides by toll-like receptors","volume":"32","author":"M Morr","year":"2002","journal-title":"Eur J Immunol"},{"issue":"3","key":"ref57","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.4049\/jimmunol.1101121","article-title":"TLR2 is a primary receptor for Alzheimer&apos;s amyloid beta peptide to trigger neuroinflammatory activation","volume":"188","author":"S Liu","year":"2012","journal-title":"J Immunol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/ncomms2534","article-title":"Neuron-released oligomeric alpha-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia","volume":"4","author":"C Kim","year":"2013","journal-title":"Nat Commun"},{"issue":"2","key":"ref59","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00401-016-1648-8","article-title":"Toll-like receptor 2 is increased in neurons in Parkinson&apos;s disease brain and may contribute to alpha-synuclein pathology","volume":"133","author":"N Dzamko","year":"2017","journal-title":"Acta Neuropathol"},{"issue":"6","key":"ref60","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/glia.22973","article-title":"Toll-like receptor-mediated immune response inhibits prion propagation","volume":"64","author":"SG Kang","year":"2016","journal-title":"Glia"},{"issue":"3851","key":"ref61","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1126\/science.162.3851.361","article-title":"Chemotactic and anaphylatoxic fragment cleaved from the fifth component of guinea pig complement","volume":"162","author":"HS Shin","year":"1968","journal-title":"Science"},{"issue":"3\u20134","key":"ref62","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/BF01988727","article-title":"The anaphylatoxins C3a and C5a are vasodilators in the canine coronary vasculature in vitro and in vivo","volume":"34","author":"WA Schumacher","year":"1991","journal-title":"Agents Actions"},{"issue":"3","key":"ref63","first-page":"749","article-title":"Effect of C3a and C5a anaphylatoxins on guinea-pig isolated blood vessels","volume":"230","author":"F Marceau","year":"1984","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"ref64","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.4049\/jimmunol.168.4.1919","article-title":"Expression and function of the C5a receptor in rat alveolar epithelial cells","volume":"168","author":"NC Riedemann","year":"2002","journal-title":"J Immunol"},{"issue":"2","key":"ref65","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/eji.1830200204","article-title":"Recombinant C5a enhances interleukin 1 and tumor necrosis factor release by lipopolysaccharide-stimulated monocytes and macrophages","volume":"20","author":"JM Cavaillon","year":"1990","journal-title":"Eur J Immunol"},{"issue":"1\u20133","key":"ref66","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0014-5793(03)00060-7","article-title":"Complement component anaphylatoxins upregulate chemokine expression by human astrocytes","volume":"537","author":"AC Jauneau","year":"2003","journal-title":"FEBS Lett"},{"issue":"9","key":"ref67","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1096\/fj.02-0737com","article-title":"Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells","volume":"17","author":"T Monsinjon","year":"2003","journal-title":"FASEB J"},{"issue":"2","key":"ref68","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s12017-009-8085-y","article-title":"The role of the complement system and the activation fragment C5a in the central nervous system","volume":"12","author":"TM Woodruff","year":"2010","journal-title":"Neuromolecular Med"},{"issue":"2","key":"ref69","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.4049\/jimmunol.0901005","article-title":"Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer&apos;s disease","volume":"183","author":"MI Fonseca","year":"2009","journal-title":"J Immunol"},{"issue":"2","key":"ref70","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1471-4159.2010.06595.x","article-title":"Microglial C5aR (CD88) expression correlates with amyloid-beta deposition in murine models of Alzheimer&apos;s disease","volume":"113","author":"RR Ager","year":"2010","journal-title":"J Neurochem"},{"issue":"1","key":"ref71","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13024-017-0210-z","article-title":"Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss","volume":"12","author":"MX Hernandez","year":"2017","journal-title":"Mol Neurodegener"},{"issue":"6","key":"ref72","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.4049\/jimmunol.169.6.3223","article-title":"Complement-induced impairment of innate immunity during sepsis","volume":"169","author":"MS Huber-Lang","year":"2002","journal-title":"J Immunol"},{"issue":"13","key":"ref73","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1096\/fj.03-0009fje","article-title":"Neutrophil C5a receptor and the outcome in a rat model of sepsis","volume":"17","author":"RF Guo","year":"2003","journal-title":"FASEB J"},{"issue":"4","key":"ref74","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/08941930600778263","article-title":"The role of complement, C5a and its receptors in sepsis and multiorgan dysfunction syndrome","volume":"19","author":"MA Flierl","year":"2006","journal-title":"J Invest Surg"},{"issue":"16","key":"ref75","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1002\/glia.21070","article-title":"Microglia in the degenerating brain are capable of phagocytosis of beads and of apoptotic cells, but do not efficiently remove PrPSc, even upon LPS stimulation","volume":"58","author":"MM Hughes","year":"2010","journal-title":"Glia"},{"issue":"8","key":"ref76","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.4049\/jimmunol.1301355","article-title":"Inflammatory responses induced by lipopolysaccharide are amplified in primary human monocytes but suppressed in macrophages by complement protein C5a","volume":"191","author":"V Seow","year":"2013","journal-title":"J Immunol"},{"issue":"3","key":"ref77","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/glia.20928","article-title":"Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll-like receptor-mediated neuronal injury","volume":"58","author":"S Lehnardt","year":"2010","journal-title":"Glia"},{"issue":"3","key":"ref78","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/imm.12134","article-title":"Innate and adaptive immune responses in neurodegeneration and repair","volume":"141","author":"S Amor","year":"2014","journal-title":"Immunology"},{"issue":"2","key":"ref79","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/imm.12233","article-title":"Inflammation in neurodegenerative diseases\u2014an update","volume":"142","author":"S Amor","year":"2014","journal-title":"Immunology"},{"issue":"2","key":"ref80","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-2567.2009.03225.x","article-title":"Inflammation in neurodegenerative diseases","volume":"129","author":"S Amor","year":"2010","journal-title":"Immunology"},{"issue":"12","key":"ref81","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.3390\/v4123389","article-title":"Prion disease and the innate immune system","volume":"4","author":"BM Bradford","year":"2012","journal-title":"Viruses"},{"issue":"24","key":"ref82","doi-asserted-by":"crossref","first-page":"13433","DOI":"10.1128\/JVI.02072-13","article-title":"Absence of CD14 delays progression of prion diseases accompanied by increased microglial activation","volume":"87","author":"K Sakai","year":"2013","journal-title":"J Virol"},{"issue":"2","key":"ref83","doi-asserted-by":"crossref","first-page":"e0117208","DOI":"10.1371\/journal.pone.0117208","article-title":"Prion pathogenesis in the absence of NLRP3\/ASC inflammasomes","volume":"10","author":"M Nuvolone","year":"2015","journal-title":"PLoS One"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0208559","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T18:52:44Z","timestamp":1720896764000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0208559"}},"subtitle":[],"editor":[{"given":"Roberto","family":"Chiesa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,12,31]]},"references-count":83,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,12,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0208559","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,31]]}}}